Taro Pharmaceutical Industries Ltd TARO Income Statements

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Revenue	156.67M	130.5M	139.2M	146.59M	158.89M	148.2M	157.15M	164.94M
Operating Income	13.98M	-6.82M	1.28M	9.27M	-7.92M	4.74M	15.91M	8.79M
Pre Tax Income	16.05M	-4.91M	9.17M	17.9M	5.44M	17.66M	33.34M	26.23M
Net Income	14.08M	-2.81M	7.27M	6.91M	10.03M	8.55M	20.21M	15.08M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	14.42M	-6.42M	1.84M	10.33M	-7.53M	5.31M	17.73M	10.98M
EBITDA	20.95M	201k	8.61M	20.08M	-30k	12.35M	23.28M	17.01M

Year End March 30 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Revenue	879.39M	661.91M	673.57M	644.77M	548.97M	561.35M	572.95M	629.18M
Operating Income	514.95M	303.01M	296.19M	246.54M	-413.78M	63.47M	17.71M	21.51M
Pre Tax Income	560.8M	292.37M	356.85M	298.04M	-391.07M	77.86M	38.21M	82.67M
Net Income	456.36M	211.15M	281.78M	244.24M	-386.65M	58.27M	25.45M	53.87M
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	11.264	5.355	7.311	6.384	-10.194	1.55	0.677	1.433
EBIT	526.16M	304.9M	298M	249.55M	-410.88M	67.7M	20.18M	26.49M
EBITDA	530.06M	319.51M	314.79M	267.92M	-390.1M	89.39M	49.85M	52.6M